Nanomedicine, Drug transportation, Drug-delivery technologies, Cosmetics, Encapsulation, Medical devices, Hydrogels, CDMO.
CIDETEC is a private applied research organisation founded in 1997 which aims to add value to companies by attracting, generating and transferring technological knowledge. CIDETEC is based in the Gipuzkoa Science and Technology Park in Donostia-San Sebastian and is made up of three international benchmark technology centres in the fields of energy storage, surface engineering and nanomedicine.
CIDETEC Nanomedicine is a centre dedicated to developing innovative materials in the field of biomedicine. The centre bases its activity on creating its own technology and currently has six patent families. Its direct contact with industry enables it to complete technology transfer by reducing time to market.
The centre develops drug-delivery technologies, encapsulation systems for cosmetic ingredients and biomaterials for developing medical devices.
Each of these centres has its own site and facilities equipped with state-of-the-art equipment. CIDETEC Nanomedicine has 600 m2 of laboratories dedicated to R&D, including a pilot plant for the encapsulation of cosmetic ingredients, and 150 m2 of areas classified and set up for manufacturing products for the biopharmaceutical sector in accordance with GMP standards.
The laboratory is set up for sterile product manufacturing with the capacity to produce small batch sizes of lyophilised products and small volume liquid vials.
DESCRIPTION
CIDETEC is a private applied research organisation founded in 1997 which aims to add value to companies by attracting, generating and transferring technological knowledge. CIDETEC is based in the Gipuzkoa Science and Technology Park in Donostia-San Sebastian and is made up of three international benchmark technology centres in the fields of energy storage, surface engineering and nanomedicine.
CIDETEC Nanomedicine is a centre dedicated to developing innovative materials in the field of biomedicine. The centre bases its activity on creating its own technology and currently has six patent families. Its direct contact with industry enables it to complete technology transfer by reducing time to market.
The centre develops drug-delivery technologies, encapsulation systems for cosmetic ingredients and biomaterials for developing medical devices.
Each of these centres has its own site and facilities equipped with state-of-the-art equipment. CIDETEC Nanomedicine has 600 m2 of laboratories dedicated to R&D, including a pilot plant for the encapsulation of cosmetic ingredients, and 150 m2 of areas classified and set up for manufacturing products for the biopharmaceutical sector in accordance with GMP standards.
The laboratory is set up for sterile product manufacturing with the capacity to produce small batch sizes of lyophilised products and small volume liquid vials.
Keywords
Nanomedicine, Drug transportation, Drug-delivery technologies, Cosmetics, Encapsulation, Medical devices, Hydrogels, CDMO.
